Operating Income (Quarterly)

Operating Income: The income after operating expenses.

ImmuCell Corporation (ICCC) had Operating Income of $0.02M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$5.51M
Net Income	$-0.14M
Cost of Goods Sold	$3.14M
Gross Profit	$2.36M
Operating Expenses	$5.49M
Operating Income	$0.02M
Non-Operating Income/Expense	$-0.16M
Pre-Tax Income	$-0.14M
Normalized Pre-Tax Income	$-0.14M
Income after Taxes	$-0.14M
Income from Continuous Operations	$-0.14M
Consolidated Net Income/Loss	$-0.14M
Normalized Income after Taxes	$-0.14M
EBIT	$0.02M
EBITDA	$0.73M
Weighted-Average Shares Outstanding (Basic)	9.05M
Weighted-Average Shares Outstanding (Diluted)	9.05M
Earnings per Share (EPS) (Basic)	$-0.02
Earnings per Share (EPS) (Diluted)	$-0.02
Balance Sheet Financials
Current Assets	$16.83M
Property, Plant, and Equipment	$24.34M
Long-Term Assets	$28.91M
Total Assets	$45.73M
Current Liabilities	$4.00M
Long-Term Debt	$7.90M
Long-Term Liabilities	$11.93M
Total Liabilities	$15.93M
Common Equity	$29.80M
Tangible Shareholders Equity	$29.70M
Shareholders Equity	$29.80M
Common Shares Outstanding	9.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.99M
Cash Flow from Investing Activities	$-1.05M
Cash Flow from Financial Activities	$-0.82M
Beginning Cash	$3.76M
End Cash	$3.89M
Increase/Decrease in Cash	$0.13M
Stock-Based Compensation	$0.19M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.21
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.32
Gross Margin	42.92%
Operating Margin	0.36%
EBIT Margin	0.36%
EBITDA Margin	--
Pre-Tax Profit Margin	-2.46%
Profit Margin	-2.54%
Free Cash Flow	$0.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.32
Receiveable Turnover	2.16
Days Sales in Receivables	41.76
Return on Equity	-0.47%
Return on Tangible Equity	-0.47%
Return on Assets	-0.31%
Return on Investments	-0.37%
Book Value Per Share	$3.29
Free Cash Flow per Share	$0.10
Operating Cash Flow per Share	$0.22

Data from Zacks Investment Research, Inc.